日前，以我校医学基础研究中心博士后Saber Imani为第一作者，博士后指导导师傅俊江教授为通讯作者的论文“The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis”在《Oncotarget》上在线发表。《Oncotarget》的SCI影响因子（IF）为：5.008。

傅俊江教授课题组主要从事表观遗传学与肿瘤生物学的研究，所取得的成果均在国家自然科学基金、四川省科技厅、四川省高校创新团队等项目资助下完成。

2017年傅俊江教授课题组已累计发表了SCI论文5篇（其中5分以上SCI论文3篇），其它4篇是：1. Diagnosis for choroideremia in a large Chinese pedigree by next‑generation sequencing (NGS) and non‑invasive prenatal testing (NIPT)；2. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-‎TFs)‎and inhibits breast cancer cell migration and invasion；3.Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China；4. Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments。